Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
The Journal of Nutrition|February 11, 2023
Vitamin B-12 Intake from Dairy but Not Meat Is Associated with Decreased Risk of Low Vitamin B-12 Status and Deficiency in Older Adults from Quebec, CanadaHe Helen Huang, Alan A Cohen, Pierrette Gaudreau, et al.
Functional & Integrative Genomics|August 20, 2016
miR-216 and miR-217 expression is reduced in transgenic mouse models of pancreatic adenocarcinoma, knockout of miR-216/miR-217 host gene is embryonic lethalAna Clara P Azevedo-Pouly, Dhruvitkumar S Sutaria, Jinmai Jiang, et al.
Cell Reports. Medicine|September 20, 2023
Adenosine A2A receptor is a tumor suppressor of NASH-associated hepatocellular carcinomaBertrand Allard, Célia Jacoberger-Foissac, Isabelle Cousineau, et al.
Gastroenterology|November 15, 2006
The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor signaling in colon cancerUlrike Stein, Franziska Arlt, Wolfgang Walther, et al.
Cancer Research|September 1, 2017
CD73 Promotes Resistance to HER2/ErbB2 Antibody TherapyMartin Turcotte, David Allard, Deepak Mittal, et al.
Journal of Occupational and Environmental Medicine|February 17, 2021
Association Between Implementation of a Universal Face Mask Policy for Healthcare Workers in a Health Care System and SARS-CoV-2 Positivity Testing Rate in Healthcare WorkersDee Dee Wang, William W O'Neill, Marcus J Zervos, et al.
Journal for Immunotherapy of Cancer|March 27, 2021
High-dimensional analysis of the adenosine pathway in high-grade serous ovarian cancerYacine Bareche, Sandra Pommey, Mayra Carneiro, et al.
Oncogene|February 19, 2026
The deubiquitinase USP17 regulates the expression and activity of the oncogenic driver β-catenin in colorectal cancerMariana Acevedo, Florence Dô, Firas El-Mortada, et al.
Oncotarget|July 1, 2016
Globally increased ultraconserved noncoding RNA expression in pancreatic adenocarcinomaJinmai Jiang, Ana Clara P Azevedo-Pouly, Roxana S Redis, et al.
Journal for Immunotherapy of Cancer|April 3, 2026
Targeting PAR-2 with a negative allosteric modulator increases tumor antigen presentation and potentiates anti-PD-1 immunotherapySamya Aouad, Maleck Kadiri, David Allard, et al.
Pageof 4